Black Diamond Therapeutics, Inc.·4

Mar 21, 4:04 PM ET

Raman Prakash 4

4 · Black Diamond Therapeutics, Inc. · Filed Mar 21, 2025

Insider Transaction Report

Form 4
Period: 2025-03-21
Transactions
  • Award

    Common Stock

    2025-03-21$1.88/sh+6,848$12,87416,993 total
Footnotes (2)
  • [F1]These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
  • [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on March 20, 2025.

Documents

1 file
  • 4
    form4-03212025_080359.xmlPrimary